Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-017567

Chief Scientific Officer sold 3,061 shares at $6.87 ($21,029)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heier Jeffrey S. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-02-24 Sale : show line 1 in the form 10b5-1 −3,061 $6.87 $21,029 265,998 D
Open-market sales · 3,061 sh · avg $6.87 · $21,029
Loading xslF345X05/tm257640-3_4seq1.xml…